DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 167 filers reported holding DIPLOMAT PHARMACY INC in Q3 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,246,000 | -14.3% | 1,061,560 | +5.0% | 0.00% | 0.0% |
| Q3 2019 | $4,956,000 | -33.3% | 1,011,356 | -17.1% | 0.00% | -50.0% |
| Q2 2019 | $7,433,000 | +60.7% | 1,220,554 | +53.4% | 0.00% | 0.0% |
| Q1 2019 | $4,624,000 | -53.8% | 795,907 | +7.0% | 0.00% | -50.0% |
| Q4 2018 | $10,013,000 | -43.9% | 743,876 | -19.2% | 0.00% | -33.3% |
| Q3 2018 | $17,863,000 | +37.1% | 920,281 | +80.6% | 0.01% | +50.0% |
| Q2 2018 | $13,027,000 | +129.8% | 509,651 | +81.1% | 0.00% | +100.0% |
| Q1 2018 | $5,669,000 | +38.9% | 281,347 | +38.4% | 0.00% | +100.0% |
| Q4 2017 | $4,081,000 | +4.7% | 203,328 | +8.0% | 0.00% | 0.0% |
| Q3 2017 | $3,897,000 | +48.9% | 188,186 | +6.4% | 0.00% | 0.0% |
| Q2 2017 | $2,617,000 | -5.6% | 176,796 | +1.7% | 0.00% | 0.0% |
| Q1 2017 | $2,773,000 | +88.1% | 173,882 | +48.7% | 0.00% | – |
| Q4 2016 | $1,474,000 | -64.4% | 116,971 | -20.9% | 0.00% | -100.0% |
| Q3 2016 | $4,141,000 | +7.6% | 147,857 | +34.5% | 0.00% | 0.0% |
| Q2 2016 | $3,849,000 | +33.9% | 109,965 | +4.9% | 0.00% | 0.0% |
| Q1 2016 | $2,874,000 | +7463.2% | 104,875 | +12166.1% | 0.00% | – |
| Q2 2015 | $38,000 | – | 855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |